Lithotripsy Devices Market

Executive Summary

Lithotripsy Devices Market was valued at US $1.76 billion in 2021 and is projected to grow at 5.63% CAGR over the forecast period to reach US $2.45 billion by 2027. Lithotripsy Devices Market represented US $0.18 billion opportunity over 2019-2021 and estimated to create US $0.69 billion opportunity in 2027 over 2021.

Lithotripsy Devices from Consainsights analyses the Lithotripsy Devices Market in the Life Sciences industry over the forecast period to 2027.

Lithotripsy Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Lithotripsy Devices segmentation includes Type, Application, End User, Region and Geography.

Based on the Type, the Lithotripsy Devices analysis covers Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices.

In Type segment, Extracorporeal Shock Wave Lithotripsy Devices segment has highest cagr growth of 4.99%.

Based on the Application, the Lithotripsy Devices analysis covers Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones.

In Application segment, Kidney Stones segment has highest cagr growth of 4.99%.

Based on the End User, the Lithotripsy Devices analysis covers Hospitals, Ambulatory Surgical Centers, Other End Users.

In End User segment, Hospitals segment has highest cagr growth of 4.99%.

Based on the Region, the Lithotripsy Devices analysis covers North America, Europe, Asia, Rest of the World.

In Region segment, North America segment has highest cagr growth of 4.99%.

Based on the region, the Lithotripsy Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Siemens AG, Storz Medical AG, Boston Scientific, Olympus, Richard Wolf, Direxgroup, Novamedtek, Dornier Medtech, Medispec, Walz Elektronik and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Intracorporeal Lithotripsy Devices segment has the highest revenue of US $0.95 billion and is expected to grow at CAGR of 4.99% by 2027 Extracorporeal Shock Wave Lithotripsy Devices segment has highest cagr growth of 4.99%.

Extracorporeal Shock Wave Lithotripsy Devices

Extracorporeal Shock Wave Lithotripsy Devices segment was valued at US $0.73 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $1.14 billion by 2027. Extracorporeal Shock Wave Lithotripsy Devices segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.32 billion opportunity in 2027 over 2021.

Intracorporeal Lithotripsy Devices

Intracorporeal Lithotripsy Devices segment was valued at US $0.85 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $1.31 billion by 2027. Intracorporeal Lithotripsy Devices segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.37 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Kidney Stones segment has the highest revenue of US $0.86 billion and is expected to grow at CAGR of 4.99% by 2027 Kidney Stones segment has highest cagr growth of 4.99%.

Kidney Stones

Kidney Stones segment was valued at US $0.77 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $1.20 billion by 2027. Kidney Stones segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.34 billion opportunity in 2027 over 2021.

Ureteral Stones

Ureteral Stones segment was valued at US $0.53 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.83 billion by 2027. Ureteral Stones segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.23 billion opportunity in 2027 over 2021.

Pancreatic Stones

Pancreatic Stones segment was valued at US $0.19 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.30 billion by 2027. Pancreatic Stones segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.08 billion opportunity in 2027 over 2021.

Bile Duct Stones

Bile Duct Stones segment was valued at US $0.08 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.12 billion by 2027. Bile Duct Stones segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $0.98 billion and is expected to grow at CAGR of 4.99% by 2027 Hospitals segment has highest cagr growth of 4.99%.

Hospitals

Hospitals segment was valued at US $0.88 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $1.36 billion by 2027. Hospitals segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.38 billion opportunity in 2027 over 2021.

Ambulatory Surgical Centers

Ambulatory Surgical Centers segment was valued at US $0.47 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.73 billion by 2027. Ambulatory Surgical Centers segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.20 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $0.23 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.36 billion by 2027. Other End Users segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $0.94 billion and is expected to grow at CAGR of 4.99% by 2027 North America segment has highest cagr growth of 4.99%.

North America

North America segment was valued at US $0.84 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $1.31 billion by 2027. North America segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.37 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $0.36 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.56 billion by 2027. Europe segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.16 billion opportunity in 2027 over 2021.

Asia

Asia segment was valued at US $0.35 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.54 billion by 2027. Asia segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.15 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $0.03 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.05 billion by 2027. Rest of the World segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.01 billion opportunity in 2027 over 2021.